Category: Life Sciences
Global Life Sciences
-
Orthopedic Orthotics
... at a CAGR of 6.4% over the analysis period 2023-2030. Lower-Limb Orthotics, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Intravenous Equipment
... at a CAGR of 3.5% over the analysis period 2023-2030. IV Catheters, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$4.8 Billion by the end of ... Read More
-
Laboratory Balances and Scales
... reach US$1.8 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Pharma & Biotech End-Use, one of the segments analyzed in the report, is expected to record a 3.8% CAGR ... Read More
-
DNA Probes-Based Diagnostics
... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$20.4 Billion ... Read More
-
Bariatric (Obesity) Surgical Devices
... reach US$5.5 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach ... Read More
-
Nucleic Acid Testing
... by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 ... Read More
-
Anti-Infectives
... of 6.2% over the analysis period 2023-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. ... Read More
-
Clinical Trial Management Systems (CTMS)
... is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 14.5% over the analysis period 2023-2030. Enterprise-Wide CTMS, one of the segments analyzed in the report, is expected to record a 15.0% ... Read More
-
Vertebral Compression Fracture Devices
... reach US$1.4 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More
-
Antimicrobial Plastics
... at a CAGR of 7.2% over the analysis period 2023-2030. Commodity Plastics, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$44.6 Billion by the end of ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Prenatal Diagnostics
... at a CAGR of 12.7% over the analysis period 2023-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$10.6 Billion by the end of ... Read More
-
Global Veterinary Molecular Diagnostics Market Research Report 2024(Status and Outlook)
... analyzing the DNA or RNA or other proteins in humans and animals. The Global Veterinary Molecular Diagnostics Market Size was estimated at USD 393.02 million in 2023 and is projected to reach USD 576.71 million ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Empty Capsules Market Report by Type (Gelatin Capsule, Non-gelatin Capsule), Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl Methylcellulose (HPMC), and Others), Functionality (Immediate-release Capsules, Sustained-release Capsules, Delayed-release Capsules), Therapeutic Application (Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Cardiovascular Therapy Drugs, and Others), End User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, and Others), and Region 2024-2032
... Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Cardiovascular Therapy Drugs, and Others), End User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, and Others), and Region 2024-2032 The global empty capsules market size reached US$ 3.1 ... Read More
-
Breast Pumps
... at a CAGR of 9.6% over the analysis period 2023-2030. Battery Powered Breast Pumps, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$3.9 Billion by the ... Read More
-
Freeze Drying Equipment
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Tray-Style Freeze Dryers, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$5.6 Billion ... Read More
-
Immunochemicals
... of 5.2% over the analysis period 2023-2030. Catalog Antibodies, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
-
Epigenetics
... of 13.3% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Companion Diagnostics
... at a CAGR of 2.1% over the analysis period 2023-2030. Companion Diagnostics Assay kits & Reagents, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$9.7 Billion ... Read More
-
e-Clinical Trial Technologies
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Clinical Trial Management Systems (CTMS), one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach ... Read More
-
BioImaging Technologies
... at a CAGR of 15.0% over the analysis period 2023-2030. Medical Technology, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$19.5 Billion by the end of ... Read More
-
X-ray Inspection Systems
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Digital Imaging Technique, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$925.2 Million ... Read More
-
Diabetes Diagnostics
... at a CAGR of 8.6% over the analysis period 2023-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of ... Read More
-
Tuberculosis Testing
... at a CAGR of 5.1% over the analysis period 2023-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$714.5 Million by the end of ... Read More
Research Assistance
